Aurora Cannabis (ACB) Cash from Discontinued Operations (2018 - 2026)
Aurora Cannabis (ACB) posted quarterly Cash from Discontinued Operations of 9410000.0 for Q1 2026, down 1128.6% year-on-year from 914833.97 in Q1 2025, and down 198.88% on a QoQ basis from 9517000.0 in Q4 2025.
Aurora Cannabis (ACB) Cash from Discontinued Operations (2018 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Cash from Discontinued Operations for 9 consecutive years, with 9410000.0 the latest figure, recorded in Q1 2026.
- Quarterly Cash from Discontinued Operations fell 1128.6% year-over-year to 9410000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 28180088.79 (up 143.83% YoY) and the FY2026 annual result came in at 4112273.44, down 186.32% from the prior year.
- Cash from Discontinued Operations declined to 9410000.0 in Q1 2026 per ACB's latest filing, from 9517000.0 in the prior quarter.
- Over the last five years, Cash from Discontinued Operations for ACB reached as high as 28839000.0 in Q4 2024 and fell as low as 30882000.0 in Q3 2023.
- A 5-year average of 3547598.9 and a median of 4333234.88 in 2022 frame the typical range for Cash from Discontinued Operations.
- Annual changes were most pronounced in 2022 — Cash from Discontinued Operations tumbled 1864.71% — and 2024, when it jumped 647.85%.
- Year by year, Cash from Discontinued Operations stood at 7811997.98 in 2022, then surged by 32.62% to 5264000.0 in 2023, then soared by 647.85% to 28839000.0 in 2024, then tumbled by 67.0% to 9517000.0 in 2025, then sank by 198.88% to 9410000.0 in 2026.
- According to Business Quant data, Cash from Discontinued Operations over the past three periods registered 9410000.0, 9517000.0, and 765911.21 for Q1 2026, Q4 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.46 Bn | 87.60 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.62 Bn | 30.68 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.27 Bn | 18.47 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.47 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn | - |
| 10 | Aurora Cannabis | 155.22 Mn | 69.97 Mn | 21.72 Mn | -9.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.41 Mn |
| Mar 31, 2026 | -9.41 Mn |
| Dec 31, 2025 | 9.52 Mn |
| Dec 31, 2025 | 9.52 Mn |
| Mar 31, 2025 | -765,911.21 |
| Mar 31, 2025 | -765,911.21 |
| Dec 31, 2024 | 28.84 Mn |
| Dec 31, 2024 | 28.84 Mn |
| Sep 30, 2024 | -24.89 Mn |
| Sep 30, 2024 | -24.89 Mn |
| Jun 30, 2024 | 8.38 Mn |
| Jun 30, 2024 | 8.38 Mn |
| Mar 31, 2024 | -457,141.74 |
| Mar 31, 2024 | -457,141.74 |
| Dec 31, 2023 | -5.26 Mn |
| Dec 31, 2023 | -5.26 Mn |
| Sep 30, 2023 | -30.88 Mn |
| Sep 30, 2023 | -30.88 Mn |
| Dec 31, 2022 | -7.81 Mn |
| Dec 31, 2022 | -7.81 Mn |